A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer
- DOI
- 10.1016/j.ejps.2026.107702
- Published
- 2026-11
- Container
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejps.2026.107702,
title = {A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer},
author = {Pouya Namakshenas and Roxan F.C.P.A Helderman and Wim Ceelen and H. Petra Kok and Johannes Crezee},
year = {2026},
journal = {European Journal of Pharmaceutical Sciences},
doi = {10.1016/j.ejps.2026.107702},
url = {https://doi.org/10.1016/j.ejps.2026.107702}
}RIS
TY - JOUR TI - A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer AU - Pouya Namakshenas AU - Roxan F.C.P.A Helderman AU - Wim Ceelen AU - H. Petra Kok AU - Johannes Crezee PY - 2026 JO - European Journal of Pharmaceutical Sciences DO - 10.1016/j.ejps.2026.107702 UR - https://doi.org/10.1016/j.ejps.2026.107702 ER -
APA
Namakshenas, P., Helderman, R. F., Ceelen, W., Kok, H. P., & Crezee, J. (2026). A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2026.107702
Source records
- crossref · retrieved 2026-11-10T10:52:54.157Z